What question did this study set out to answer?

Synthesize literature on heterologous gene expression platforms and biomanufacturing technologies used to produce recombinant L-asparaginase.

January 1, 2025Biomedical Chemistry Research and MethodsOpen Access

Heterologous Expression of Recombinant L-asparaginase Genes

View Full Paper

Ask AI

Bookmark

Authors

MPM. V. Pokrovskaya SAS. Alexandrova VPVadim S. Pokrovsky

Discussion

Member takes

Overview

Review synthesizes heterologous expression strategies for recombinant L-asparaginase production across diverse platforms, highlighting technological advances for industrial and clinical supply.

Key Points

Synthesize literature on heterologous gene expression platforms and biomanufacturing technologies used to produce recombinant L-asparaginase.
Literature synthesis of recombinant expression strategies spanning cell-free, bacterial, insect, plant, and mammalian systems.
Evaluation of expression technologies focused on industrial scalability and therapeutic quality for L-asparaginase (EC 3.5.1.1).
Cataloged diverse cellular host systems capable of high-yield production of recombinant L-asparaginase for biomedical and food processing applications.
Identified optimization of expression hosts as essential for overcoming yield limitations and satisfying global production demands.

Cite This Study

Pokrovskaya et al. (2025) studied this question.

synapsesocial.com/papers/6a15731d79ff98d0de4ea580 https://doi.org/10.18097/bmcrm00265

View Full Paper

Ask AI

Bookmark

January 1, 2025Biomedical Chemistry Research and MethodsOpen Access

Heterologous Expression of Recombinant L-asparaginase Genes

View Full Paper

Ask AI

Bookmark

Authors

MPM. V. Pokrovskaya SAS. Alexandrova VPVadim S. Pokrovsky

Discussion

Member takes

Overview

Review synthesizes heterologous expression strategies for recombinant L-asparaginase production across diverse platforms, highlighting technological advances for industrial and clinical supply.

Key Points

Synthesize literature on heterologous gene expression platforms and biomanufacturing technologies used to produce recombinant L-asparaginase.
Literature synthesis of recombinant expression strategies spanning cell-free, bacterial, insect, plant, and mammalian systems.
Evaluation of expression technologies focused on industrial scalability and therapeutic quality for L-asparaginase (EC 3.5.1.1).
Cataloged diverse cellular host systems capable of high-yield production of recombinant L-asparaginase for biomedical and food processing applications.
Identified optimization of expression hosts as essential for overcoming yield limitations and satisfying global production demands.

Cite This Study

Pokrovskaya et al. (2025) studied this question.

synapsesocial.com/papers/6a15731d79ff98d0de4ea580 https://doi.org/10.18097/bmcrm00265

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

View Full Paper

Ask AI

Bookmark